Back to state act
Description
On 8 April 2020, the Federal Agency for Medicines and Health Products (FAMHP) introduced a licensing requirement on exports of certain pharmaceutical drugs to countries outside the European Economic A...
Sign in to see full description
Intervention Details
Intervention Type
Export licensing requirement
MAST Chapter
P: Export-related measures (incl. subsidies)
Implementation date
08 Apr 2020
Revocation date
No revocation date
Implementation level
National
Affected flow
Outward
Announced as temporary
No
Eligible firms
all
Affected Trading Partners
Table
Affected Sectors
Sign in to access 2 sectors
Affected Products
Sign in to access 18 products
Threads
See all
This intervention is not part of any Thread yet.